Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma

Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma

Antonio Miguel,1 Luis Sendra,1 Verónica Noé,2 Carles J Ciudad,2 Francisco Dasí,3,4 David Hervas,5 María José Herrero,1,6 Salvador F Aliño17 1Department of Pharmacology, Faculty of Medicine, University of Valencia, 2Department of Bioc...

Full description

Bibliographic Details
Main Authors: Miguel A, Sendra L, Noé V, Ciudad CJ, Dasi F, Hervas D, Herrero MJ, Aliño SF
Format: Article
Language:English
Published: Dove Medical Press 2017-01-01
Series:OncoTargets and Therapy
Subjects:
gene silencing
antitumor vaccine
Treg
antisense oligonucleotide
cancer immunotherapy
Online Access:https://www.dovepress.com/silencing-of-foxp3-enhances-the-antitumor-efficacy-of-gm-csf-genetical-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/silencing-of-foxp3-enhances-the-antitumor-efficacy-of-gm-csf-genetical-peer-reviewed-article-OTT

Similar Items